EyeC reports growth in key business areas in Q4 2022 EP News Bureau Dec 17, 2022 The American partner EyeC America contributed to this with an order intake above the €2 million mark
Eris Lifesciences’s Q2FY23 revenue up 28 per cent YoY EP News Bureau Oct 21, 2022 EBITDA at Rs 1,514 million, with 32.9 per cent EBITDA margin; PAT stood at Rs 1,194 million, with 25.9 per cent PAT margin
